Skip to content
Screener

ICU Medical ICUI Infusion Consumables — Revenue

Similar metrics at other companies

WAT
WATConsumables — Revenue
$543M+293%
STERIS logo
STEConsumables — Revenue
$473.4M+9.0%
10x Genomics, Inc. logo
TXGConsumables — Revenue
$130.75M+7.0%
TEC
TECHConsumables — Revenue
$257.34M-0.2%
ALM
ALMRConsumables — Revenue
$13.96M+178%
Ollie's Bargain Outlet Holdings, Inc. logo
OLLIConsumables — Revenue
$226.95M+20.1%

Other financials

Income statement

See full
Revenue$551.7M+0.5%
Gross profit$235.1M+13.0%
Operating income$39.1M+270%
Net income$19.1M-46.0%
EPS (diluted)$0.76-46.9%

Balance sheet

See full
Cash & equivalents$298.3M-0.6%
Total debt$1.3B-7.1%
Total equity$2.2B+1.7%
Total assets$4.0B-3.3%

Cash flow

See full
Operating cash flow$80.2M+615%
CapEx$18.5M-6.0%
Free cash flow$61.6M

Valuation

See full
Market cap$4.16B+33.1%
Enterprise value$5.17B+22.2%
P/E51.2×
P/S1.9×+0.6×

Profitability

See full
Gross margin39.1%+3.3pp
Operating margin3.3%+0.4pp
Net margin-0.3%-0.2pp
FCF margin7.1%+4.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.1×
Current ratio2.4×0.0×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: ICU Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000883984-26-000041
Product lineThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Consumables$289,276$273,133$567,551$539,359
Infusion Systems188,998167,696368,602333,996
Vital Care (1)73,409108,037145,755280,213
Total Revenues$551,683$548,866$1,081,908$1,153,568

Item 1. Financial Statements (Unaudited)

FAQ

What is ICU Medical's infusion consumables — revenue?
ICU Medical (ICUI) reported infusion consumables — revenue of $289.28M in Q2 2026.
How has ICU Medical's infusion consumables — revenue changed year-over-year?
ICU Medical's infusion consumables — revenue increased by 5.9% year-over-year, from $273.13M to $289.28M.
What is the long-term trend for ICU Medical's infusion consumables — revenue?
Over 4 years (2021 to 2025), ICU Medical's infusion consumables — revenue has grown at a 18.9% compound annual growth rate (CAGR), from $555.19M to $1.11B.
What does infusion consumables — revenue mean?
This metric represents the total gross sales generated from the sale of single-use infusion therapy products, such as IV sets, connectors, and catheters. It serves as a primary indicator of market demand and adoption for the company's core disposable medical supplies within the infusion continuum. Tracking this revenue stream helps investors assess the stability and growth trajectory of the company's recurring product base.

Ask your AI about ICU Medical's infusion consumables — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude